LONDON--(BUSINESS WIRE)--Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, notes the publication today of the final phase I data from the first ever ...
The “Open Data for Data Users” e-learning course is designed to provide a broad overview of Open Data from a user standpoint, and empower anyone to take full advantage of Open Data. Open Data is a ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Seismic Therapeutic, Inc., the machine learning immunology company, today announced the presentation of preclinical data for its immunoglobulin E (IgE) protease, ...
Data is presented at the 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) / World Allergy Organization (WAO) Joint Congress "We believe we are at the forefront of an emerging field to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results